_id
6919ebc13c536f8df231839d
Ticker
N4P.LSE
Name
N4 Pharma PLC
Exchange
LSE
Address
8 Bishopsgate, London, United Kingdom, EC2N 4BQ
Country
UK
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
GBX
Website
https://www.n4pharma.com
Description
N4 Pharma Plc, a specialist pharmaceutical company, develops nanoparticle silica delivery systems to enhance the cellular delivery and potency of cancer treatments and vaccines in the United Kingdom. It develops Nuvec, a silica nanoparticle delivery system, which has an irregular surface structure that traps and protects siRNA/RNA/DNA; and Liptide, a platform to deliver a proprietary siRNA sequence to silence a fibrotic gene. The company also engages in the development of N4 101, an orally delivered inflammation inhibitor which is in the pre-clinical development for treatment of inflammatory bowel disease; and ECP105 for the prevention of ocular scarring. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Last Close
5250
Volume
18152
Current Price
0.482
Change
0
Last Updated
2025-12-30T11:17:24.497Z
Image
https://logo.clearbit.com/www.n4pharma.com
Ipo Date
-
Market Cap
4369471
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
3690
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
473906
Operating Income
-470216
Interest Expense
-
Pretax Income
-470216
Net Income
-498550
Eps
-0.0008647123506137435
Dividends Per Share
-
Shares Outstanding
832280349
Income Tax Expense
31378
EBITDA
-470216
Operating Margin
-12742.981029810298
Total Other Income Expense Net
-
Cash
1727543
Short Term Investments
-
Receivables
118113
Inventories
-
Total Current Assets
1845656
Property Plant Equipment
-
Total Assets
1845656
Payables
28263
Short Term Debt
-
Long Term Debt
-
Total Liabilities
78367
Equity
1766579
Bs_currency_symbol
GBP
Depreciation
-
Change In Working Capital
-45695
Cash From Operations
-444367
Capital Expenditures
3
Cash From Investing
-
Cash From Financing
1545938
Net Change In Cash
1101571
Cf_currency_symbol
-
PE
-
PB
157.30808106402262
ROE
-28.221211731827445
ROA
-27.012075923140603
FCF
-444370
Fcf Percent
-120.42547425474255
Piotroski FScore
1
Health Score
27
Deep Value Investing Score
4
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
3
Growth Investing Score
1.5
Momentum Investing Score
2
Net Net Investing Score
3
Quality Investing Score
2.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
3690
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
473906
Quarters > 0 > income Statement > operating Income
-470216
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-470216
Quarters > 0 > income Statement > net Income
-498550
Quarters > 0 > income Statement > eps
-0.0008647123506137435
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
576550109
Quarters > 0 > income Statement > income Tax Expense
31378
Quarters > 0 > income Statement > EBITDA
-470216
Quarters > 0 > income Statement > operating Margin
-12742.981029810298
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
1727543
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
118113
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
1845656
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
1845656
Quarters > 0 > balance Sheet > payables
28263
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
78367
Quarters > 0 > balance Sheet > equity
1766579
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-498550
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-45695
Quarters > 0 > cash Flow > cash From Operations
-444367
Quarters > 0 > cash Flow > capital Expenditures
3
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
1545938
Quarters > 0 > cash Flow > net Change In Cash
1101571
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.0008647123506137435
Quarters > 0 > ratios > PB
157.30808106402262
Quarters > 0 > ratios > ROE
-28.221211731827445
Quarters > 0 > ratios > ROA
-27.012075923140603
Quarters > 0 > ratios > FCF
-444370
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-120.42547425474255
Quarters > 0 > health Score
27
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
3376
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
3376
Quarters > 1 > income Statement > operating Expenses
734429
Quarters > 1 > income Statement > operating Income
-669843
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-729000
Quarters > 1 > income Statement > net Income
-604000
Quarters > 1 > income Statement > eps
-0.0017718793361906355
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
340881000
Quarters > 1 > income Statement > income Tax Expense
-101000
Quarters > 1 > income Statement > EBITDA
-731000
Quarters > 1 > income Statement > operating Margin
-19841.321090047393
Quarters > 1 > income Statement > total Other Income Expense Net
-59553
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
625972
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
134667
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
775769
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
775769
Quarters > 1 > balance Sheet > payables
23324
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
124367
Quarters > 1 > balance Sheet > equity
647647
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
-
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.0017718793361906355
Quarters > 1 > ratios > PB
253.69474729289257
Quarters > 1 > ratios > ROE
-93.26068058680114
Quarters > 1 > ratios > ROA
-77.8582284159331
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
3906
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
3906
Quarters > 2 > income Statement > operating Expenses
493954
Quarters > 2 > income Statement > operating Income
-490048
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-491705
Quarters > 2 > income Statement > net Income
-454867
Quarters > 2 > income Statement > eps
-0.0015938114898381768
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
285395734
Quarters > 2 > income Statement > income Tax Expense
-36838
Quarters > 2 > income Statement > EBITDA
-491708
Quarters > 2 > income Statement > operating Margin
-12546.031746031746
Quarters > 2 > income Statement > total Other Income Expense Net
-1657
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
1204946
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
69021
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
1273967
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
1335177
Quarters > 2 > balance Sheet > payables
11613
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
56041
Quarters > 2 > balance Sheet > equity
1249969
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-454867
Quarters > 2 > cash Flow > depreciation
-1660
Quarters > 2 > cash Flow > change In Working Capital
92339
Quarters > 2 > cash Flow > cash From Operations
-390869
Quarters > 2 > cash Flow > capital Expenditures
1
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
568703
Quarters > 2 > cash Flow > net Change In Cash
177834
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.0015938114898381768
Quarters > 2 > ratios > PB
110.05132430324271
Quarters > 2 > ratios > ROE
-36.39026247850946
Quarters > 2 > ratios > ROA
-34.06791758695664
Quarters > 2 > ratios > FCF
-390870
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-100.06912442396313
Quarters > 2 > health Score
27
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
1953
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
1953
Quarters > 3 > income Statement > operating Expenses
781641
Quarters > 3 > income Statement > operating Income
-780000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-778000
Quarters > 3 > income Statement > net Income
-623000
Quarters > 3 > income Statement > eps
-0.002461312357526361
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
253117000
Quarters > 3 > income Statement > income Tax Expense
-148000
Quarters > 3 > income Statement > EBITDA
-780000
Quarters > 3 > income Statement > operating Margin
-39938.556067588324
Quarters > 3 > income Statement > total Other Income Expense Net
1244
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
1027112
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
176432
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1214157
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
1275367
Quarters > 3 > balance Sheet > payables
20202
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
81726
Quarters > 3 > balance Sheet > equity
1127636
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
-623181
Quarters > 3 > cash Flow > depreciation
-32910
Quarters > 3 > cash Flow > change In Working Capital
35109
Quarters > 3 > cash Flow > cash From Operations
-580582
Quarters > 3 > cash Flow > capital Expenditures
2
Quarters > 3 > cash Flow > cash From Investing
781
Quarters > 3 > cash Flow > cash From Financing
317144
Quarters > 3 > cash Flow > net Change In Cash
-262657
Quarters > 3 > cash Flow > currency_symbol
GBP
Quarters > 3 > ratios > PE
-0.002461312357526361
Quarters > 3 > ratios > PB
108.1930640738678
Quarters > 3 > ratios > ROE
-55.24832481403573
Quarters > 3 > ratios > ROA
-48.848684339488166
Quarters > 3 > ratios > FCF
-580584
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-297.2780337941628
Quarters > 3 > health Score
27
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
7282
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
7282
Annuals > 0 > income Statement > operating Expenses
1167173
Annuals > 0 > income Statement > operating Income
-1221000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-1221000
Annuals > 0 > income Statement > net Income
-1059000
Annuals > 0 > income Statement > eps
-0.0031066559884534487
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
340881000
Annuals > 0 > income Statement > income Tax Expense
-101000
Annuals > 0 > income Statement > EBITDA
-1221000
Annuals > 0 > income Statement > operating Margin
-16767.37160120846
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
625972
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
134667
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
775769
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
775769
Annuals > 0 > balance Sheet > payables
23324
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
124367
Annuals > 0 > balance Sheet > equity
647647
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-1119989
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
33185
Annuals > 0 > cash Flow > cash From Operations
-971500
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
570360
Annuals > 0 > cash Flow > net Change In Cash
-401140
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.0031066559884534487
Annuals > 0 > ratios > PB
284.22233099203737
Annuals > 0 > ratios > ROE
-163.51500122752054
Annuals > 0 > ratios > ROA
-136.50970843124693
Annuals > 0 > ratios > FCF
-971500
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-133.411150782752
Annuals > 0 > health Score
27
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1953
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
1953
Annuals > 1 > income Statement > operating Expenses
1427000
Annuals > 1 > income Statement > operating Income
-1425000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-1425000
Annuals > 1 > income Statement > net Income
-1269000
Annuals > 1 > income Statement > eps
-0.005224587261723414
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
242890000
Annuals > 1 > income Statement > income Tax Expense
-148000
Annuals > 1 > income Statement > EBITDA
-1335000
Annuals > 1 > income Statement > operating Margin
-72964.66973886329
Annuals > 1 > income Statement > total Other Income Expense Net
-4
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
1027112
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
176432
Annuals > 1 > balance Sheet > inventories
-176432
Annuals > 1 > balance Sheet > total Current Assets
1214157
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
1275367
Annuals > 1 > balance Sheet > payables
20202
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
81726
Annuals > 1 > balance Sheet > equity
1127636
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-1269331
Annuals > 1 > cash Flow > depreciation
89175
Annuals > 1 > cash Flow > change In Working Capital
48068
Annuals > 1 > cash Flow > cash From Operations
-1209098
Annuals > 1 > cash Flow > capital Expenditures
2
Annuals > 1 > cash Flow > cash From Investing
781
Annuals > 1 > cash Flow > cash From Financing
315900
Annuals > 1 > cash Flow > net Change In Cash
-892417
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.005224587261723414
Annuals > 1 > ratios > PB
116.31466182349625
Annuals > 1 > ratios > ROE
-112.53631491013056
Annuals > 1 > ratios > ROA
-99.50077115057861
Annuals > 1 > ratios > FCF
-1209100
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-619.0988223246288
Annuals > 1 > health Score
26
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
1193260
Annuals > 2 > income Statement > operating Income
-1193260
Annuals > 2 > income Statement > interest Expense
1
Annuals > 2 > income Statement > pretax Income
-1193259
Annuals > 2 > income Statement > net Income
-1029261
Annuals > 2 > income Statement > eps
-0.0055211052284321145
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
186423000
Annuals > 2 > income Statement > income Tax Expense
-163998
Annuals > 2 > income Statement > EBITDA
-1193260
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
1
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
1919529
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
209630
Annuals > 2 > balance Sheet > inventories
-209630
Annuals > 2 > balance Sheet > total Current Assets
2166047
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
2166047
Annuals > 2 > balance Sheet > payables
35756
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
77889
Annuals > 2 > balance Sheet > equity
2088158
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-1029261
Annuals > 2 > cash Flow > depreciation
228485
Annuals > 2 > cash Flow > change In Working Capital
-172153
Annuals > 2 > cash Flow > cash From Operations
-828263
Annuals > 2 > cash Flow > capital Expenditures
3
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
963768
Annuals > 2 > cash Flow > net Change In Cash
135505
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.0055211052284321145
Annuals > 2 > ratios > PB
48.20919681365108
Annuals > 2 > ratios > ROE
-49.29037936784477
Annuals > 2 > ratios > ROA
-47.51794397813159
Annuals > 2 > ratios > FCF
-828266
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
27
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
1843290
Annuals > 3 > income Statement > operating Income
-1843290
Annuals > 3 > income Statement > interest Expense
677
Annuals > 3 > income Statement > pretax Income
-1842613
Annuals > 3 > income Statement > net Income
-1544346
Annuals > 3 > income Statement > eps
-0.008528528827037774
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
181080000
Annuals > 3 > income Statement > income Tax Expense
-298267
Annuals > 3 > income Statement > EBITDA
-1843290
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
677
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
1784024
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
551346
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
2342383
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
2342383
Annuals > 3 > balance Sheet > payables
180346
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
212730
Annuals > 3 > balance Sheet > equity
2129653
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-1544346
Annuals > 3 > cash Flow > depreciation
236558
Annuals > 3 > cash Flow > change In Working Capital
54393
Annuals > 3 > cash Flow > cash From Operations
-1772232
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
677
Annuals > 3 > cash Flow > net Change In Cash
-1771555
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-0.008528528827037774
Annuals > 3 > ratios > PB
45.91508569705957
Annuals > 3 > ratios > ROE
-72.51632073394117
Annuals > 3 > ratios > ROA
-65.93055021318034
Annuals > 3 > ratios > FCF
-1772232
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
27
Valuation > metrics > PE
-0.0008647123506137435
Valuation > metrics > PB
157.30808106402262
Valuation > final Score
20
Valuation > verdict
5143.6% Overvalued
Profitability > metrics > ROE
-28.221211731827445
Profitability > metrics > ROA
-27.012075923140603
Profitability > metrics > Net Margin
-135.10840108401084
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.04436088054935556
Risk > final Score
80
Risk > verdict
Low
Liquidity > metrics > Current Ratio
65.30290485794148
Liquidity > metrics > Quick Ratio
65.30290485794148
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-1280
Prev Risks > 1
-653337
Prev Risks > 2
-1500
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:02:53.040Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-09-25
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-06-06
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-12-31
Earnings History > 2 > report Date
2025-03-31
Earnings History > 2 > date
2024-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-12-31
Earnings History > 3 > report Date
2023-03-09
Earnings History > 3 > date
2022-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
GBP
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-06-30
Earnings History > 4 > report Date
2022-09-29
Earnings History > 4 > date
2022-06-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2021-12-31
Earnings History > 5 > report Date
2022-02-23
Earnings History > 5 > date
2021-12-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
-0.01
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-06-30
Earnings History > 6 > report Date
2021-09-20
Earnings History > 6 > date
2021-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
GBP
Earnings History > 6 > eps Actual
-0.01
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2020-12-31
Earnings History > 7 > report Date
2021-02-22
Earnings History > 7 > date
2020-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
GBP
Earnings History > 7 > eps Actual
0
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-06-30
Earnings History > 8 > report Date
2020-09-17
Earnings History > 8 > date
2020-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
GBP
Earnings History > 8 > eps Actual
-0.0047
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.0047
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-12-31
Earnings History > 9 > report Date
2020-03-02
Earnings History > 9 > date
2019-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
GBP
Earnings History > 9 > eps Actual
0
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2019-06-30
Earnings History > 10 > report Date
2019-09-18
Earnings History > 10 > date
2019-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
GBP
Earnings History > 10 > eps Actual
-0.0053
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.0053
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2019-03-31
Earnings History > 11 > report Date
2019-05-14
Earnings History > 11 > date
2019-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
GBP
Earnings History > 11 > eps Actual
-0.01
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.01
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-06-30
Earnings History > 12 > report Date
2018-09-20
Earnings History > 12 > date
2018-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
GBP
Earnings History > 12 > eps Actual
-0.01
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.01
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2017-12-31
Earnings History > 13 > report Date
2018-03-21
Earnings History > 13 > date
2017-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
GBP
Earnings History > 13 > eps Actual
-0.01
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.01
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-06-30
Earnings History > 14 > report Date
2017-09-25
Earnings History > 14 > date
2017-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
GBP
Earnings History > 14 > eps Actual
-0.03
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.03
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2016-12-31
Earnings History > 15 > report Date
2017-03-23
Earnings History > 15 > date
2016-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
GBP
Earnings History > 15 > eps Actual
0
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2016-06-30
Earnings History > 16 > report Date
2016-09-30
Earnings History > 16 > date
2016-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
GBP
Earnings History > 16 > eps Actual
0
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2015-12-31
Earnings History > 17 > report Date
2016-02-03
Earnings History > 17 > date
2015-12-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
GBP
Earnings History > 17 > eps Actual
-0.01
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.01
Earnings History > 17 > surprise Percent
-
N4 Pharma Plc, a specialist pharmaceutical company, develops nanoparticle silica delivery systems to enhance the cellular delivery and potency of cancer treatments and vaccines in the United Kingdom. It develops Nuvec, a silica nanoparticle delivery system, which has an irregular surface structure that traps and protects siRNA/RNA/DNA; and Liptide, a platform to deliver a proprietary siRNA sequence to silence a fibrotic gene. The company also engages in the development of N4 101, an orally delivered inflammation inhibitor which is in the pre-clinical development for treatment of inflammatory bowel disease; and ECP105 for the prevention of ocular scarring. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of N4 Pharma PLC
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.